• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙轻症新冠肺炎患者的嗅觉和味觉障碍

Smell and taste disorders in Spanish patients with mild COVID-19.

作者信息

Barón-Sánchez J, Santiago C, Goizueta-San Martín G, Arca R, Fernández R

机构信息

Servicio de Neurofisiología Clínica, Complejo Asistencial de Zamora, Zamora, España.

Servicio de Neurofisiología Clínica, Complejo Asistencial de Zamora, Zamora, España.

出版信息

Neurologia (Engl Ed). 2020 Nov-Dec;35(9):633-638. doi: 10.1016/j.nrl.2020.07.006. Epub 2020 Jul 28.

DOI:10.1016/j.nrl.2020.07.006
PMID:32900532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7543781/
Abstract

INTRODUCTION

Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world. Smell and/or taste disorders have emerged as a very frequent symptom as the disease has spread in Europe. Spain is one of the European countries with the highest number of infections.

OBJECTIVE

This study aimed to investigate the clinical progression of smell and taste disorders in Spanish patients with mild COVID-19.

METHODS

An online survey was used to conduct a cross-sectional study of patients who presented sudden smell and/or taste disorders during the 2 months of total lockdown due to COVID-19 in Spain.

RESULTS

In our sample, 91.18% of respondents with impaired smell and/or taste and who were able to undergo PCR testing were positive for SARS-CoV-2 infection. Anosmia and ageusia presented in isolation in 6.5% of participants. The remaining 93.5% presented other mild symptoms: headache (51.6%), cough (51.6%), myalgia (45.2%), asthaenia (38.7%), nasal congestion or rhinorrhoea (35.5%), fever (41.9%), low-grade fever (29.0%), odynophagia (25.8%), or diarrhoea (6.5%). The mean duration of anosmia was 8.33 days, with patients subsequently manifesting hyposmia; complete resolution occurred after a mean of 17.79 days. In 22.6% of respondents, olfactory deficits persisted. All participants recovered their sense of taste.

CONCLUSIONS

Olfactory and gustatory disorders are prevalent symptoms in mild COVID-19. Most patients do not present associated nasal congestion or rhinorrhoea and a small group of patients present these alterations in isolation.

摘要

引言

2019年冠状病毒病(COVID-19)已在全球迅速传播。随着该疾病在欧洲蔓延,嗅觉和/或味觉障碍已成为一种非常常见的症状。西班牙是欧洲感染人数最多的国家之一。

目的

本研究旨在调查西班牙轻症COVID-19患者嗅觉和味觉障碍的临床进展。

方法

采用在线调查对西班牙因COVID-19全面封锁的2个月内出现突发嗅觉和/或味觉障碍的患者进行横断面研究。

结果

在我们的样本中,嗅觉和/或味觉受损且能够接受PCR检测的受访者中,91.18%的人SARS-CoV-2感染呈阳性。6.5%的参与者单独出现嗅觉丧失和味觉丧失。其余93.5%的人出现其他轻微症状:头痛(51.6%)、咳嗽(51.6%)、肌痛(45.2%)、乏力(38.7%)、鼻塞或流涕(35.5%)、发热(41.9%)、低热(29.0%)、吞咽痛(25.8%)或腹泻(6.5%)。嗅觉丧失的平均持续时间为8.33天,随后患者表现为嗅觉减退;平均17.79天后完全恢复。22.6%的受访者嗅觉缺陷持续存在。所有参与者都恢复了味觉。

结论

嗅觉和味觉障碍是轻症COVID-19的常见症状。大多数患者没有伴有鼻塞或流涕,一小部分患者单独出现这些改变。

相似文献

1
Smell and taste disorders in Spanish patients with mild COVID-19.西班牙轻症新冠肺炎患者的嗅觉和味觉障碍
Neurologia (Engl Ed). 2020 Nov-Dec;35(9):633-638. doi: 10.1016/j.nrl.2020.07.006. Epub 2020 Jul 28.
2
[Smell and taste disorders in Spanish patients with mild COVID-19].[西班牙轻症新冠肺炎患者的嗅觉和味觉障碍]
Neurologia. 2020 Nov-Dec;35(9):633-638. doi: 10.1016/j.nrl.2020.07.006. Epub 2020 Jul 28.
3
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.嗅觉和味觉障碍作为冠状病毒病(COVID-19)轻至中度形式的临床特征:一项多中心欧洲研究。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.
4
Smell and Taste Dysfunction in COVID-19 Is Associated With Younger Age in Ambulatory Settings: A Multicenter Cross-Sectional Study.在门诊环境中,COVID-19 嗅觉和味觉障碍与年龄较小有关:一项多中心横断面研究。
J Investig Allergol Clin Immunol. 2020;30(5):346-357. doi: 10.18176/jiaci.0595. Epub 2020 Jun 17.
5
Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.味觉和嗅觉功能障碍与以流感样症状就诊的 COVID-19 患者的关联。
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813. doi: 10.1002/alr.22579. Epub 2020 Jun 1.
6
Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.新型冠状病毒肺炎患者急性嗅觉或味觉丧失的流行率和持续时间。
J Korean Med Sci. 2020 May 11;35(18):e174. doi: 10.3346/jkms.2020.35.e174.
7
Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (COVID-19): a systematic review.突发性、急性丧失味觉和嗅觉与 2019 年冠状病毒病(COVID-19):系统评价。
Acta Odontol Scand. 2020 Aug;78(6):467-473. doi: 10.1080/00016357.2020.1787505. Epub 2020 Aug 7.
8
Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19.突发嗅觉丧失在COVID-19诊断中的预测价值
ORL J Otorhinolaryngol Relat Spec. 2020;82(4):175-180. doi: 10.1159/000509143. Epub 2020 Jun 11.
9
Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.新冠病毒感染患者的嗅觉功能障碍和鼻-鼻窦症状:流行率、严重程度、出现时间和相关特征。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-120. doi: 10.1177/0194599820929185. Epub 2020 May 19.
10
Taste and Smell Impairment in COVID-19: An AAO-HNS Anosmia Reporting Tool-Based Comparative Study.COVID-19 患者的味觉和嗅觉障碍:一项基于 AAO-HNS anosmia 报告工具的比较研究。
Otolaryngol Head Neck Surg. 2020 Sep;163(3):473-479. doi: 10.1177/0194599820931820. Epub 2020 Jun 9.

引用本文的文献

1
[Oral manifestations of COVID-19 and the role of the ACE2 receptor: what is known so far?].[新型冠状病毒肺炎的口腔表现及血管紧张素转换酶2受体的作用:目前已知情况如何?]
Rev Cient Odontol (Lima). 2022 Jun 27;10(2):e108. doi: 10.21142/2523-2754-1002-2022-108. eCollection 2022 Apr-Jun.
2
Loss of Sour Taste Is the Striking Feature among Four Basic Taste Qualities in Tunisian COVID-19 Patients.味觉丧失是突尼斯新冠肺炎患者四种基本味觉中的显著特征。
J Clin Med. 2023 Jan 11;12(2):597. doi: 10.3390/jcm12020597.
3
The aftermath of COVID-19: between anosmia and ageusia.新冠疫情的后遗症:嗅觉丧失与味觉丧失之间
Acta Otorrinolaringol Esp (Engl Ed). 2022 May-Jun;73(3):200. doi: 10.1016/j.otoeng.2021.07.003. Epub 2022 Mar 3.
4
Olfactory and Taste Disorders in Patients Suffering from Covid-19, a Review of Literature.新冠病毒感染患者的嗅觉和味觉障碍:文献综述
J Dent (Shiraz). 2022 Mar;23(1):1-6. doi: 10.30476/DENTJODS.2021.87800.1284.
5
Exploring the Clinical Utility of Gustatory Dysfunction (GD) as a Triage Symptom Prior to Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the Diagnosis of COVID-19: A Meta-Analysis and Systematic Review.探索味觉功能障碍(GD)作为新冠病毒疾病(COVID-19)诊断中逆转录聚合酶链反应(RT-PCR)之前的分诊症状的临床效用:一项荟萃分析和系统评价。
Life (Basel). 2021 Nov 29;11(12):1315. doi: 10.3390/life11121315.
6
Small fiber neuropathy in the cornea of Covid-19 patients associated with the generation of ocular surface disease.新冠病毒感染者角膜中的小纤维神经病与眼表疾病的产生有关。
Ocul Surf. 2022 Jan;23:40-48. doi: 10.1016/j.jtos.2021.10.010. Epub 2021 Nov 12.
7
[The aftermath of COVID-19: between anosmia and ageusia].[新冠疫情的后遗症:嗅觉丧失与味觉丧失之间]
Acta Otorrinolaringol Esp. 2022 May-Jun;73(3):200. doi: 10.1016/j.otorri.2021.07.002. Epub 2021 Oct 7.
8
Factors influencing the COVID-19 mortality rate in the European Union: importance of medical professionals.影响欧盟 COVID-19 死亡率的因素:医疗专业人员的重要性。
Public Health. 2021 Nov;200:1-3. doi: 10.1016/j.puhe.2021.09.003. Epub 2021 Sep 15.
9
Influenza and anosmia: Important prediction factors for severity and death of COVID-19.流感与嗅觉丧失:COVID-19严重程度和死亡的重要预测因素。
J Infect. 2021 Nov;83(5):e10-e13. doi: 10.1016/j.jinf.2021.08.024. Epub 2021 Aug 19.
10
Characterization of Headache in COVID-19: a Retrospective Multicenter Study.COVID-19 相关头痛特征:一项回顾性多中心研究。
Mol Neurobiol. 2021 Sep;58(9):4487-4494. doi: 10.1007/s12035-021-02430-w. Epub 2021 May 25.

本文引用的文献

1
The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.单细胞 RNA 测序表达谱分析受体 ACE2 和细胞蛋白酶 TMPRSS2,揭示了人类易感染 SARS-CoV-2 的器官。
Int J Environ Res Public Health. 2021 Jan 2;18(1):284. doi: 10.3390/ijerph18010284.
2
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
3
An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection.一项针对 SARS-CoV-2 感染后嗅觉和味觉改变患者的在线观察性研究。
Front Public Health. 2020 May 29;8:243. doi: 10.3389/fpubh.2020.00243. eCollection 2020.
4
Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia.一名2019冠状病毒病(COVID-19)合并嗅觉丧失患者的脑磁共振成像改变
JAMA Neurol. 2020 Aug 1;77(8):1028-1029. doi: 10.1001/jamaneurol.2020.2125.
5
Is the brain a reservoir organ for SARS-CoV2?大脑是新冠病毒的储存器官吗?
J Med Virol. 2020 Nov;92(11):2354-2355. doi: 10.1002/jmv.26046. Epub 2020 Jun 2.
6
First ultrastructural autoptic findings of SARS -Cov-2 in olfactory pathways and brainstem.严重急性呼吸综合征冠状病毒2型在嗅觉通路和脑干中的首次超微结构尸检结果
Minerva Anestesiol. 2020 Jun;86(6):678-679. doi: 10.23736/S0375-9393.20.14772-2. Epub 2020 May 13.
7
Olfactory and Gustatory Dysfunction in Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)中的嗅觉和味觉功能障碍
Clin Infect Dis. 2020 Nov 19;71(16):2262-2264. doi: 10.1093/cid/ciaa525.
8
Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的中枢神经系统受累。
J Med Virol. 2020 Jul;92(7):699-702. doi: 10.1002/jmv.25915.
9
Should we expect neurological symptoms in the SARS-CoV-2 epidemic?在新冠疫情中我们应该预期会出现神经症状吗?
Neurologia (Engl Ed). 2020 Apr;35(3):170-175. doi: 10.1016/j.nrl.2020.03.001. Epub 2020 Apr 6.
10
SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection.SARS-CoV-2:嗅觉、脑部感染,以及对允许更早检测病毒的临床样本的迫切需求。
ACS Chem Neurosci. 2020 May 6;11(9):1200-1203. doi: 10.1021/acschemneuro.0c00172. Epub 2020 Apr 13.